Results 161 to 170 of about 7,490 (233)

Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers. [PDF]

Front Oncol
Kluitmans DJF, Melis JJTM, van den Bossche E, Ytsma J, de Roos JADM, van Linden OPJ, Grobben Y, Kooijman JJ, Zaman GJR.   +8 more
europepmc   +1 more source

Cost impact of Bruton's tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia. [PDF]

J Comp Eff Res
Kittai AS, Patel DA, Shafrin J, Zawadzki N, Shetty VS, Barqawi YK, Rhodes JM.   +6 more
europepmc   +1 more source

RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. [PDF]

J Transl Int Med
Dong XD, Lu Q, Li YD, Cai CY, Teng QX, Lei ZN, Wei ZH, Yin F, Zeng L, Chen ZS.   +9 more
europepmc   +1 more source

Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma. [PDF]

J Oncol Pharm Pract
Lu J, Do B, Primeaux B, Primeaux B.
europepmc   +1 more source

小児科学 [PDF]

, 2002
宮脇 利男, 市田 蕗子, 本郷 和久, 松倉 裕喜, 橋本 郁夫, 濱道 裕二, 足立 雄一, 野村 恵子, 金兼 弘和   +8 more
core   +2 more sources

Inhibition of bruton's tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis. [PDF]

J Neuroinflammation
Xiao Z, Li Z, Zhu W, Chen G, Luo X, Mai Z, Wang M, Huang H, Li Z, Shi Y, Xie Y, Wu H, Chen X, Liang D.   +13 more
europepmc   +1 more source

Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy. [PDF]

Cancer Cell
Phelan JD, Scheich S, Choi J, Wright GW, Häupl B, Young RM, Rieke SA, Pape M, Ji Y, Urlaub H, Bolomsky A, Doebele C, Zindel A, Wotapek T, Kasbekar M, Collinge B, Huang DW, Coulibaly ZA, Morris VM, Zhuang X, Enssle JC, Yu X, Xu W, Yang Y, Zhao H, Wang Z, Tran AD, Shoemaker CJ, Shevchenko G, Hodson DJ, Shaffer AL, Staudt LM, Oellerich T.   +32 more
europepmc   +1 more source

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. [PDF]

J Exp Clin Cancer Res
Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, Guo X, Zhao P.   +7 more
europepmc   +1 more source

Retraction: Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice. [PDF]

Front Immunol
Frontiers Editorial Office.
europepmc   +1 more source

Bruton's tyrosine kinase (Btk) と結合する新規分子の同定とその解析 [PDF]

マツシタ, マサト, 松下, 正人
core